HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu Zhu Selected Research

Liver Neoplasms (Liver Cancer)

2/2022Single cell multi-miRNAs quantification with hydrogel microbeads for liver cancer cell subtypes discrimination.
1/2020MLK3 is a newly identified microRNA-520b target that regulates liver cancer cell migration.
1/2020Cinobufagin Triggers Defects in Spindle Formation and Cap-Dependent Translation in Liver Cancer Cells by Inhibiting the AURKA-mTOR-eIF4E Axis.
1/2019High miR-139-3p expression predicts a better prognosis for hepatocellular carcinoma: a pooled analysis.
1/2018NEDD4 promotes cell growth and motility in hepatocellular carcinoma.
3/2016HULC long noncoding RNA silencing suppresses angiogenesis by regulating ESM-1 via the PI3K/Akt/mTOR signaling pathway in human gliomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu Zhu Research Topics

Disease

213Neoplasms (Cancer)
05/2024 - 01/2005
36Inflammation (Inflammations)
11/2024 - 07/2005
33Neoplasm Metastasis (Metastasis)
03/2024 - 06/2010
32Hemorrhagic Shock
01/2023 - 04/2010
31Urinary Bladder Neoplasms (Bladder Cancer)
05/2024 - 07/2015
27Renal Cell Carcinoma (Grawitz Tumor)
01/2023 - 01/2013
26Infections
03/2024 - 04/2005
24Hepatocellular Carcinoma (Hepatoma)
04/2024 - 11/2010
23Wounds and Injuries (Trauma)
12/2023 - 05/2013
23Hypoxia (Hypoxemia)
01/2023 - 08/2010
18Sepsis (Septicemia)
04/2024 - 12/2015
18Glioma (Gliomas)
01/2023 - 01/2013
16Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2024 - 01/2013
16Hemorrhage
11/2023 - 02/2005
15Carcinogenesis
04/2024 - 06/2010
15Stomach Neoplasms (Stomach Cancer)
02/2021 - 07/2010
14Carcinoma (Carcinomatosis)
02/2024 - 06/2007
14Shock
01/2022 - 08/2010
13Pheochromocytoma
01/2023 - 06/2006
12Pain (Aches)
05/2024 - 12/2007
12Prostatic Neoplasms (Prostate Cancer)
08/2022 - 03/2006
11Septic Shock (Toxic Shock Syndrome)
04/2024 - 07/2011
11Lung Neoplasms (Lung Cancer)
12/2023 - 06/2008
11BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2021 - 11/2008
10Breast Neoplasms (Breast Cancer)
03/2024 - 06/2012
10Type 2 Diabetes Mellitus (MODY)
11/2023 - 01/2017
10Hypertension (High Blood Pressure)
09/2023 - 05/2011
10Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
11/2022 - 01/2018
9Melanoma (Melanoma, Malignant)
01/2024 - 03/2009
8Insulin Resistance
05/2024 - 01/2020
8Obesity
05/2024 - 02/2010
8Colorectal Neoplasms (Colorectal Cancer)
04/2024 - 06/2007
8Body Weight (Weight, Body)
03/2024 - 10/2005
8Non-alcoholic Fatty Liver Disease
01/2024 - 11/2016
8Cardiovascular Diseases (Cardiovascular Disease)
09/2023 - 05/2015
8Necrosis
11/2020 - 07/2008
8Leukemia
10/2018 - 06/2010
7Asthma (Bronchial Asthma)
11/2024 - 03/2011
7Reperfusion Injury
04/2024 - 01/2013
7Fever (Fevers)
06/2023 - 08/2016
7Osteoporosis
04/2023 - 01/2018
7Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 08/2015
7Adrenocortical Carcinoma
01/2022 - 12/2011
7Nausea
01/2019 - 11/2013
6Disease Progression
01/2024 - 09/2002
6Hematologic Neoplasms (Hematological Malignancy)
11/2023 - 12/2008
6Rupture
11/2023 - 04/2013
6Ischemic Stroke
08/2023 - 01/2012

Drug/Important Bio-Agent (IBA)

53Proteins (Proteins, Gene)FDA Link
01/2024 - 10/2005
40Biomarkers (Surrogate Marker)IBA
02/2024 - 08/2013
28CytokinesIBA
11/2024 - 03/2002
21MicroRNAs (MicroRNA)IBA
01/2024 - 04/2013
20Messenger RNA (mRNA)IBA
04/2024 - 07/2005
19Glucose (Dextrose)FDA LinkGeneric
01/2024 - 07/2011
17Therapeutic UsesIBA
11/2024 - 04/2009
15Oxygen (Dioxygen)IBA
08/2023 - 08/2013
14LipidsIBA
01/2024 - 06/2012
14Long Noncoding RNAIBA
12/2023 - 03/2016
14Insulin (Novolin)FDA Link
09/2023 - 01/2013
13LipopolysaccharidesIBA
01/2024 - 05/2015
12Anti-Bacterial Agents (Antibiotics)IBA
01/2024 - 02/2012
10EnzymesIBA
11/2023 - 01/2013
10Interleukin-6 (Interleukin 6)IBA
10/2023 - 01/2014
10rho-Associated KinasesIBA
11/2016 - 08/2010
9Phosphotransferases (Kinase)IBA
04/2024 - 01/2013
9RNA (Ribonucleic Acid)IBA
01/2024 - 04/2006
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2023 - 05/2011
9DecitabineFDA Link
06/2023 - 01/2013
9C-Reactive ProteinIBA
05/2023 - 12/2017
9Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2023 - 04/2005
9Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2022 - 03/2002
9alkylglycerone-phosphate synthaseIBA
01/2021 - 07/2014
8CalciumIBA
04/2024 - 11/2011
8InterleukinsIBA
04/2024 - 08/2013
8Tyrosine Kinase InhibitorsIBA
01/2023 - 08/2013
8BilirubinIBA
01/2023 - 05/2015
8Peptides (Polypeptides)IBA
01/2023 - 03/2002
7Immune Checkpoint InhibitorsIBA
02/2024 - 06/2019
7CateninsIBA
08/2023 - 12/2014
7Hemoglobins (Hemoglobin)IBA
01/2023 - 08/2013
7Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023 - 05/2013
7Blood Glucose (Blood Sugar)IBA
05/2022 - 04/2015
7DNA (Deoxyribonucleic Acid)IBA
01/2020 - 06/2006
7Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2020 - 08/2014
7Arginine Vasopressin (Argipressin)IBA
12/2019 - 07/2011
6Circular RNAIBA
01/2024 - 09/2016
6Antiviral Agents (Antivirals)IBA
12/2023 - 10/2016
6CarbohydratesIBA
01/2023 - 03/2015

Therapy/Procedure

96Therapeutics
05/2024 - 09/2004
31Drug Therapy (Chemotherapy)
02/2024 - 11/2007
20Ligation
04/2024 - 11/2003
20Immunotherapy
03/2024 - 09/2014
20Resuscitation
01/2023 - 01/2011
16Punctures
04/2024 - 05/2015
12Radiotherapy
01/2024 - 10/2014
11Length of Stay
11/2021 - 12/2007
10Nephrectomy
01/2023 - 08/2010
10Adjuvant Chemotherapy
11/2022 - 01/2018
8Aftercare (After-Treatment)
01/2024 - 04/2015
8Adrenalectomy
01/2023 - 12/2007